69f73cc3_anderbilt_Ingram_Cancer_Center__Trial_Type
[Protocol No. & Open Date] VICCUROP1468 12/04/2014 [Summary] A Phase 1b, Open Label, Dose Finding Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of Axitinib (AG-013736) in Combination with MK-3475 in Patients with Advanced Renal Cell Cancer [Trial Type] 
Treatment Kidney (Renal Cell)
Urologic / Genitourinary Cancers - Vanderbilt-Ingram Cancer Center
Trial Type